October 13th 2025
Three-year results from the ACCORd trial show sustained LARC use, higher satisfaction, and fewer unintended pregnancies with physician training.
September 14th 2025
Benefits of extended combined hormonal contraceptive regimens
June 5th 2024Extended combined hormonal contraceptive regimens, which include prolonged active hormone use and shorter hormone-free intervals, offer increased contraceptive efficacy, reduced menstrual symptoms, and improved management of withdrawal bleeding compared to traditional cyclic use.
Read More
Out-of-state abortion travel and care delays increased in Washington post-Dobbs
June 3rd 2024A study revealed that the Dobbs v Jackson Women’s Health Organization decision has led to more out-of-state abortions and longer gestation periods in states such as Washington with legalized abortion.
Read More
Study finds youth with developmental disabilities less likely to access reproductive health care
May 22nd 2024A recent study reveals that adolescents with autism and other developmental disabilities have fewer visits to obstetrician-gynecologists and lower hormonal contraceptive use compared to their typically developing peers, highlighting a need for improved reproductive health services.
Read More
Mastering misoprostol: Comprehensive uses across trimesters
May 17th 2024Leanne R. McCloskey, MD, and Weronika A. Armstrong, MD, xplore the multifaceted applications of misoprostol in obstetrics, covering protocols, safety, and the impact on birth equity from early pregnancy loss to labor induction at ACOG 2024.
Watch
Mail-order dispensing of mifepristone for medication abortion found effective
May 13th 2024A recent study revealed that mail-order pharmacy dispensing of mifepristone for medication abortion proves effective and satisfactory, highlighting a potential avenue for expanding access to reproductive healthcare.
Read More
Contemporary understanding of breast cancer risk with combined oral contraceptives
April 2nd 2024Unveiling the intricate relationship between combined oral contraceptive use and breast cancer risk, navigating through research insights and clinical implications for informed patient counseling.
Read More
How genetic variables impact oral contraceptive use and VTE risk
March 27th 2024A comprehensive study delved into the interplay of polygenic and hereditary factors in venous thromboembolism risk among oral contraceptive users, shedding light on potential genetic markers for refined risk assessment and counseling.
Read More
Impact of serum estradiol decline before hCG-triggering on IVF outcomes
March 13th 2024A recent study delves into how serum estradiol decline preceding human chorionic gonadotropin administration affects in vitro fertilization outcomes, particularly among patients without oral contraceptive pretreatment, shedding light on the importance of monitoring during controlled ovarian hyperstimulation.
Read More